Julia Carbonetti
Overview
Julia Carbonetti has extensive experience representing clients in class actions and complex commercial litigation as well as providing counsel on regulatory compliance and due diligence risk management. With a focus on the consumer products and transportation industries, Julia represents clients facing complex tort, product liability, and consumer protection litigation. She handles all stages of litigation, including discovery, expert discovery, dispositive motions, class certification, hearings, mediations, trial, and appeals. Julia also advises clients before any litigation is filed by efficiently developing a factual record and providing guidance that minimizes risk, limits potential liability, and offers practical business solutions.
Career & Education
- University of Maryland School of Law, J.D., cum laude, 2016
- University of Maryland, College Park, B.A., 2013
- Maryland
- District of Columbia
- U.S. District Court for the District of Maryland
- U.S. District Court for the District of Columbia
Julia's Insights
Client Alert | 11 min read | 04.23.25
Recall Litigation Report: Trends in 2024 Continue Into 2025
Looking back at 2024, manufacturers were extremely busy navigating a high number of recalled products and corresponding litigation. A number of these 2024 litigation and class action trends appear to be carrying over into 2025.
Client Alert | 3 min read | 03.27.25
MoCRA Under the Trump Era: A Look at FDA's Monitoring and Enforcement Two Months In
Publication | 02.04.25
Client Alert | 5 min read | 01.27.25
Representative Matters
- Defending major automobile manufacturer in multi-state consumer class actions asserting warranty, consumer protection, fraud, and tort claims.
- Representing companies conduct regulatory and product liability diligence on target companies and their products.
- Representing major automobile manufacturer in class action settlement proceeding to resolve multiple lawsuits asserting warranty, consumer protection, fraud, and unjust enrichment claims.
Julia's Insights
Client Alert | 11 min read | 04.23.25
Recall Litigation Report: Trends in 2024 Continue Into 2025
Looking back at 2024, manufacturers were extremely busy navigating a high number of recalled products and corresponding litigation. A number of these 2024 litigation and class action trends appear to be carrying over into 2025.
Client Alert | 3 min read | 03.27.25
MoCRA Under the Trump Era: A Look at FDA's Monitoring and Enforcement Two Months In
Publication | 02.04.25
Client Alert | 5 min read | 01.27.25
Insights
Let’s Talk All Things MoCRA – Is Your Company Prepared?
|06.11.24
MoCRA-Required Recordkeeping, Reporting Now ‘Fair Game’ For Litigants – Crowell & Moring
|08.24.23
HBW Insight
PFAS Litigation: Another Headache for the Beauty Industry
|02.27.24
Crowell & Moring’s Retail & Consumer Products Law Observer
- |
02.23.24
Crowell & Moring’s Retail & Consumer Products Law Observer
Recall Litigation Report: END OF YEAR RECAP (2023)
|01.12.24
Crowell & Moring’s Retail & Consumer Products Law Observer
- |
12.27.23
Crowell & Moring’s Retail & Consumer Products Law Observer
Benzene Continues To Be A Hot Button Issue
|10.17.23
Crowell & Moring’s Retail & Consumer Products Law Observer
Philips Reaches Settlement in CPAP/BiPAP MDL
|10.16.23
Crowell & Moring’s Retail & Consumer Products Law Observer
Modernization of Cosmetics Regulation Act (“MoCRA”) White Paper
|08.15.23
Crowell & Moring’s Retail & Consumer Products Law Observer
Recall Litigation Report: Year in Review (2022)
|01.19.23
Crowell & Moring’s Retail & Consumer Products Law Observer
Recall Litigation Report: Exactech Joint Replacement Products
|04.07.22
Crowell & Moring’s Retail & Consumer Products Law Observer
Julia's Insights
Client Alert | 11 min read | 04.23.25
Recall Litigation Report: Trends in 2024 Continue Into 2025
Looking back at 2024, manufacturers were extremely busy navigating a high number of recalled products and corresponding litigation. A number of these 2024 litigation and class action trends appear to be carrying over into 2025.
Client Alert | 3 min read | 03.27.25
MoCRA Under the Trump Era: A Look at FDA's Monitoring and Enforcement Two Months In
Publication | 02.04.25
Client Alert | 5 min read | 01.27.25
